Washington, D.C. partner Brigid DeCoursey Bondoc will be participating in a session titled “Beyond the Mainstream: Addressing Neglected Tumor Types” during Lumanity’s Cancer Progress event on Thursday, April 9, 2026, from 1:15 p.m. – 2:35 p.m. ET. The session touches on how rare and aggressive cancers are often overlooked in funding and research. The participants will discuss barriers and strategies to bring these types of cancers to the forefront of oncology innovation. They will address roadblocks in researching and drug development for these rare cancers, discuss lessons learned from cancers that were once less known, and identify top priorities to expedite progress.
To learn more about the event, visit the event website.
Brigid DeCoursey BondocPartner